Avandia Hearing Reveals Fundamental Flaws at FDA – Union of Concerned Scientists

Avandia Hearing Reveals Fundamental Flaws at FDA
Union of Concerned Scientists
The advisory panel met yesterday and today to review safety questions regarding Avandia, a GlaxoSmithKline diabetes drug that has been linked to heart
Avandia: The Key Vote Is NegativeForbes (blog)
Close the FDA Approval GapHuffington Post (blog)
Whistleblower News Roundup 7.15.10Government Accountability Project (blog)

all 5 news articles »

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>